PHARMA FEED

Sanofi Appoints Belén Garijo as CEO, Replacing Paul Hudson | Sanofi and Regeneron's Itepekimab Shows Mixed Results in COPD Trials | AstraZeneca's Imfinzi, Roche's China Expansion, and Bladder Cancer Advancements | Sanofi Appoints Belén Garijo as CEO, Replacing Paul Hudson | Sanofi and Regeneron's Itepekimab Shows Mixed Results in COPD Trials | AstraZeneca's Imfinzi, Roche's China Expansion, and Bladder Cancer Advancements

Pharma / Executive Moves

Sanofi Appoints Belén Garijo as CEO, Replacing Paul Hudson

Sanofi is set to welcome Belén Garijo as its new CEO, replacing Paul Hudson. This move comes as Sanofi aims to rejuvenate its research pipeline and identify successors for key therapies like Dupixent.

Image via Reuters

Feb 12, 2026 16:01 Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant

Pharma / Clinical Trials

Sanofi and Regeneron's Itepekimab Shows Mixed Results in COPD Trials

May 30, 2025 14:31 Next-gen COPD drug from Sanofi, Regeneron shows mixed results in Phase 3 trials

Pharma / Oncology

AstraZeneca's Imfinzi, Roche's China Expansion, and Bladder Cancer Advancements

May 13, 2025 18:31 AstraZeneca's Imfinzi hits main goal of bladder cancer study, with "no detriment" to survival

Clinical Trials Executive Moves Oncology